International Medical Journal (ISSN:13412051)

Aim and Scope

Aim-

International Medical Journal ISSN: (13412051) is an international open-access journal publishes twelve times each year. The "International Medical Journal" is a peer-reviewed, monthly, online international research journal, which publishes original articles, research articles, review articles with top-level work from all areas of Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody, ENT etc. Researchers in all Medical Science and Pharmacy fields are encouraged to contribute articles based on recent research. Journal publishes research articles and reviews within the whole field of Medical Science and Pharmacy Research, and it will continue to provide information on the latest trends and developments in this ever-expanding subject. International Medical Journal journal covers almost all disciplines of Medical Science and Pharmacy. Researchers and students of M.B.B.S, M.D., D.T.C.D., GYNE., M.S., M.Pharma, And PhD are requested to send their original research articles to International Medical Journal.

Scope-

International Medical Journal ISSN: (13412051) is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Anatomy Physiology Biochemistry Pharmacology
Pathology Forensic medicine Microbiology Community Medicine
Otorhinolaryngology Internal Medicine General Surgery Obstetrics and Gynecology
Radiology Pulmonary Medicine Dermatology and Venereal diseases Infectious Diseases AMA, Agricultural Mechanization in Asia, Africa and Latin America Teikyo Medical Journal Journal of the Mine Ventilation Society of South Africa Dokkyo Journal of Medical Sciences
Anaesthesia Cancer research Neurosurgery Orthopedics

See More Scopes

Latest Journals
International Medical Journal
Journal ID : IMJ-10-11-2020-650
Total View : 481

Abstract : The most widely recognized reason for morbidity and mortality globally is cancer. Early detection and regular follow up of high-risk patients can curb the mortality and morbidity rate. Dentists play a vital role in the early detection of oral cancer; therefore, assessing their knowledge and practice for early detection of oral cancer is crucial. A cross-sectional study was designed to assess the dentists’ knowledge and practice for the early detection of oral cancer. The study was conducted in the Qassim region among dental interns, general dental practitioners (GPs), specialists, and consultants in both private and public sectors. The questionnaire consisted of 14 closed-ended questions that contain socio-demographic characters of participants, information regarding the participants' knowledge, and practice related questions. Data collected and analysed in SPSS software v. 21 and descriptive analysis was done. A total of 159 participants in the study. Regarding the potential risks for oral cancer, 48.4% and 34.6% believed viruses and hereditary. Regarding the high-risk sites for oral cancer, 38.4% of the participants choose soft palate complex, lateral border of the tongue, and floor of the mouth as high-risk sites. The majority of the participants, i.e., 70.4% (n=112) did not use any adjunctive screening tools. 57.2% (n=91) feel they do not have sufficient knowledge concerning the early detection of oral cancer. The vast majority, i.e., 87.4% (n=139) agreed that they need more information and continuing education for the same. The survey findings suggest that there is an existing gap in the knowledge and the use of chairside diagnostic procedures for the early detection of oral cancer, one of the barriers is lack of training. Dentists’ comprehension must be reinforced and constantly updated by continuing education programs..
Full article
International Medical Journal
Journal ID : IMJ-04-11-2020-648
Total View : 371

Abstract :

The human life expectancy has increased 8% globally. Consistently, the aging population has also grown significantly. The increase of aging population is followed by many health issues, including, musculoskeletal pain. Low back pain (LBP) has been the key role of causing disability among musculoskeletal problems. Currently, American College of Physicians (ACP) recommended that nonpharmacologic treatment should be the first option in treating LBP. There are many studies about the effectiveness of cupping therapy (CT) in management LBP. Therefore, this review aims to outline the evidence of CT in treating LBP. The general conclusion of this review is CT can be a promising therapy as nonpharmacologic management of LBP.

.
Full article
International Medical Journal
Journal ID : IMJ-30-10-2020-646
Total View : 354

Abstract : For an objective and comprehensive assessment of all indicators of the quality of life of patients, the questionnaire “MOS SF-36 - Health Status Survey” was used. A specific questionnaire “Quality of life after myocardial infarction” - Quality of Life after Myocardial Infarction (QLMI) was also used. The total number of patients included in the study was 120, of whom 75 were men and 45 women, 62.5% and 37.5%, respectively. All patients were divided into three groups. The first group included 40 practical healthy patients. The second group is also represented by 40 patients who had myocardial infarction without complications, and the 3rd group included 40 patients who had myocardial infarction and who had complications. Indicators of the physical component of QL in patients with myocardial infarction in the second and third groups were reduced by a factor of 2-3 compared with the control group (1) and were significantly different in all indicators, especially in 1– Physical functioning by 60–75%, 2 - by role functioning by 30–55%, 3 by the intensity of pain by 33–73%, and 4 by the general state of health by 32.5– 52.5%. Indicators of quality of life, psychological component in patients undergoing myocardial infarction without complication and with complications, were significantly lower compared to practically healthy people in the following sequence: by vital activity by 32.5-45%, by role functioning, due to emotional state by 23, 9-57.3%, mental health by 32-44%, and social functioning by 20.5-62.5%. The results of the study showed that the indicators of the physical and psychological component of QL in patients after myocardial infarction, with and without complications, were 2-3 times lower than in the control group (p <0.05; p <0.01; p <0.001), indicating the effect of myocardial infarction on QOL.
Full article
International Medical Journal
Journal ID : IMJ-30-10-2020-645
Total View : 347

Abstract : Successful recovery of severe COVID-19 with cytokine storm with Plasma Convalescent Therapy or Extracorporeal blood purification, has been with or without methylprednisolone has been reported, but not in diabetes comorbid which in immunocompromised where cortisone is immunosuppressant. So cortisone for anti- inflammation drugs should be not recommended. This study builds the potential benefit and harm of corticosteroid in pandemic COVID-19. Systematic Review with Science Direct search engine using keywords of methylprednisolone and COVID-19 are used. Bayesian analysis and network support this study. Cytokine storm and anti- inflammation/ immunosuppressant and immunocompromised/ comorbid are used. Insulin Resistance Syndrome cases are included, and non is excluded. Pneumonia and DIC as the excess, ventilated patients are also included. Flowchart of 15 references supported the table, one table describe the references. Three Systematic Reviews, 4 case reports, 2 cohorts, 4 reviews, 2 observational with minimal 15,385 subjects. The use of corticosteroid as prevention, treatment, and rehabilitation at mild, medium, severe phases are recorded and analyzed. Cortisone is immunosuppressant stuff that should be used only in a hospitalized patient in critical severe cases in overwhelmed/ hyperinflammatory stage COVID-19 pts. but should be forbidden (not recommended is not enough) in comorbidities. Using cortisone in plant/OTC in this pandemic era should be socialized the danger in the public domain to combat the easy spread.
Full article
International Medical Journal
Journal ID : IMJ-28-10-2020-644
Total View : 343

Abstract :

More evidence confirmed the dopaminergic system involvement in ulcerative colitis (UC) pathogenesis. Genes, coding for D3 dopamine receptor were found in neuromuscular and mucosal layers in colon, as well as on immune cells mostly of primary immune response which indicates D3 receptor as the potential therapeutic target for UC. In present study we checked the hypothesize on the protective role of D3 receptor agonist in experimental models of UC. We used two models of UC: 6% iodoacetamide (IA)-induced UC in Wistar rats (0.1 ml, i.c.); and spontaneously developed colitis in IL-10 KO mice. Rats with IA-induced UC were treated with D3R agonist 7-OH-DPAT (in doses of 0.2 mg/kg and 1 mg/kg, s.c. on the 2nd and 5th days). Autopsy on the 7th day. Clinical, macroscopic and microscopic evaluation of UC were performed. It was indicated that during the normal condition D3R were localized on epithelial, endothelial and enteric neurons of rat’s colon mucosa. During the development of IA-induced UC in rats and UC in IL-10 KO mice, expression of D3R protein markedly decreased and its expression was observed mainly on the surface colonocytes. Treatment with 7-OH-DPAT in dose of 0.2 mg/kg had positive effect on clinical and morphological signs of IA-induced UC in rats. The administration of 7-OH-DPAT altered the mucus composition, also enhanced mast cell and macrophage functional reserve. Activation of D3 dopamine receptor might be the potential molecular target for UC treatment.

.
Full article

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates